Travere Therapeutics Inc (TVTX): Uncovering A True Diamond In The Rough

Travere Therapeutics Inc (NASDAQ:TVTX) currently has a daily average trading volume of 1.75M but it saw 1114754 shares traded in last market. With a market cap of 1.38B USD, the company’s current market price of $18.05 came rising about 2.04 while comparing to the previous closing price of $17.69. In past 52 weeks, the stock remained buoying in the range of price level as high as $18.60 and as low as $5.12. In the recent trading on the day, stock has struck highest price mark of $17.69 while lowest mark touched by it was $18.33.

Taking a look at 20-day trading activity of Travere Therapeutics Inc (TVTX) gives us an average price of $15.42, while its current price level is -2.96% below from 52-week high level whereas it is 252.54% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $12.30 while that of 200 days or SMA-200 reads an average of $8.99. A closer look into the stock’s movement over the week reveals that its volatility is standing at 7.52% during that period while stretching the period over a month that decreases to 7.29%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 73.55 which implies that the stock is in overbought territory.

Guggenheim upgraded its recommendation for the stock as a “Buy” from “Neutral” on September 09, 2024 while assigning a price target of $25.

Over the week, TVTX’s stock price is moving 2.62% up while it is 25.35% when we observe its performance for the past one month. Year-to-date it is 100.78% up and over the past year, the stock is showing an upside performance of 151.74%.

Currently, Travere Therapeutics Inc’s total number of outstanding shares is 75.37M. Company’s return on investment (ROI) stands at -90.01% and return on equity (ROE) at -582.60%. Stock’s beta reads 0.73. Stock has a price to book (P/B) ratio of 91.11 while price to sale or P/S ratio amounts to 7.77. Its return on asset (ROA) is -59.56% on average.